Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphoma (English)
- New search for: Vanazzi, Anna
- New search for: Grana, Chiara
- New search for: Crosta, Cristiano
- New search for: Pruneri, Giancarlo
- New search for: Rizzo, Stefania
- New search for: Radice, Davide
- New search for: Pinto, Antonello
- New search for: Calabrese, Liliana
- New search for: Paganelli, Giovanni
- New search for: Martinelli, Giovanni
- New search for: Vanazzi, Anna
- New search for: Grana, Chiara
- New search for: Crosta, Cristiano
- New search for: Pruneri, Giancarlo
- New search for: Rizzo, Stefania
- New search for: Radice, Davide
- New search for: Pinto, Antonello
- New search for: Calabrese, Liliana
- New search for: Paganelli, Giovanni
- New search for: Martinelli, Giovanni
In:
Hematological Oncology
;
32
, 1
;
10-15
;
2014
- Article (Journal) / Electronic Resource
-
Title:Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphoma
-
Contributors:Vanazzi, Anna ( author ) / Grana, Chiara ( author ) / Crosta, Cristiano ( author ) / Pruneri, Giancarlo ( author ) / Rizzo, Stefania ( author ) / Radice, Davide ( author ) / Pinto, Antonello ( author ) / Calabrese, Liliana ( author ) / Paganelli, Giovanni ( author ) / Martinelli, Giovanni ( author )
-
Published in:Hematological Oncology ; 32, 1 ; 10-15
-
Publisher:
-
Publication date:2014-03-01
-
Size:6 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 32, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?Ferrara, Felicetto et al. | 2014
- 10
-
Efficacy of 90Yttrium‐ibritumomab tiuxetan in relapsed/refractory extranodal marginal‐zone lymphomaVanazzi, Anna / Grana, Chiara / Crosta, Cristiano / Pruneri, Giancarlo / Rizzo, Stefania / Radice, Davide / Pinto, Antonello / Calabrese, Liliana / Paganelli, Giovanni / Martinelli, Giovanni et al. | 2014
- 16
-
Peripheral blood sCD3− CD4+ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphomaSingh, Anju / Schabath, Richard / Ratei, Richard / Stroux, Andrea / Klemke, Claus‐Detlev / Nebe, Thomas / Flörcken, Anne / van Lessen, Antje / Anagnostopoulos, Ioannis / Dörken, Bernd et al. | 2014
- 22
-
B‐cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalitiesFalisi, Erika / Novella, Elisabetta / Visco, Carlo / Guercini, Nicola / Maura, Francesco / Giaretta, Ilaria / Pomponi, Fabrizio / Nichele, Ilaria / Finotto, Silvia / Montaldi, Annamaria et al. | 2014
- 31
-
Cost‐effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantationBezinelli, Letícia Mello / de Paula Eduardo, Fernanda / da Graça Lopes, Roberta Marques / Biazevic, Maria Gabriela Haye / de Paula Eduardo, Carlos / Correa, Luciana / Hamerschlak, Nelson / Michel‐Crosato, Edgard et al. | 2014
- 40
-
Long‐term efficacy of low‐dose all‐trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post‐remission therapy in newly diagnosed acute promyelocytic leukaemiaLou, Yinjun / Qian, Wenbin / Meng, Haitao / Mai, Wenyuan / Tong, Hongyan / Tong, Yin / Huang, Jian / Jin, Jie et al. | 2014
- 47
-
Development of an Epstein–Barr virus‐associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemiaMenter, T / Schlageter, M / Bastian, L / Haberthür, R / Rätz Bravo, AE / Tzankov, A et al. | 2014
- 52
-
Myeloma presenting during pregnancySmith, Dean / Stevens, Jane / Quinn, John / Cavenagh, Jamie / Ingram, Wendy / Yong, Kwee et al. | 2014
- 56
-
Emerging Cancer Therapeutics: Lymphomas. John Sweetenham (guest editor). Demos Medical Publishing, 2012, New York, NY, USA. Hardcover edition, 389 pp., USD 85.00Bertoni, Francesco et al. | 2014
- i
-
Issue Information| 2014